Samuel J. Ballentine, MD

Specializes In
  • Pathology


Sees Patients For

Gastrointestinal & pancreaticobiliary pathology, liver pathology, inflammatory bowel disease


Board Certifications

  • Anatomic and Clinical Pathology

Academic Title(s)

Assistant Professor, Pathology & Immunology
Associate Residency Director
Division of Anatomic & Molecular Pathology

Research Interests

I am interested in translational clinicopathologic research related to the field of gastrointestinal, pancreaticobiliary, and liver pathology. I have specific interest and experience in the study of idiopathic inflammatory bowel disease (Crohn’s and Ulcerative colitis) and low grade appendiceal mucinous neoplasms, though I welcome outreach for collaborative projects pertaining to all areas of gastrointestinal medicine.

Publications & Research

View research profile »


Fellowship: Gastrointestinal and Liver Pathology

2019 Icahn School of Medicine at Mount Sinai, New York, NY

Residency: Anatomic and Clinical Pathology

2018 Icahn School of Medicine at Mount Sinai, New York, NY

Medical Degree

2013 New York University School of Medicine, New York, NY

Bachelor's Degree: Chemistry

2008 University of Rhode Island, Kingston, RI

Financial Disclosures
  • Elligo Health Research
    • Consulting/Advisory Board: $10,000 - $19,999
    • Reporting Date: 05/01/2023

Washington University and its physicians and health professionals are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians and health professionals work collaboratively with pharmaceutical, medical device or other medical care related companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our physicians and health professionals have an ownership or potential ownership interest in a commercial company; and/or are paid by a commercial company to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians or health professionals must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this website, physicians and health professionals earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.